Joel Tyndall

University of Otago

New Zealand

Research Interests

Explore related searches

Professors in New Zealand

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (15)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (11)

Wilhelmina Huston

University of Sydney

AUSTRALIA

View details

Michelle Glass

University of Otago

NEW ZEALAND

View details

Natasha Grimsey

University of Auckland

NEW ZEALAND

View details

Malcolm Rutledge

University of Otago

NEW ZEALAND

View details

Andrea J. Vernall

NEW ZEALAND

View details

Claire Simons

Cardiff University

UNITED KINGDOM

View details

Matthew Phillips

Associate Lecturer

University of Technology, Sydney

AUSTRALIA

View details

Brian Monk

Associate Professor

University of Otago

NEW ZEALAND

View details

Sigurd Wilbanks

Senior Lecturer

University of Otago

NEW ZEALAND

View details

Arlene McDowell

Associate Professor

University of Otago

NEW ZEALAND

View details

Christoph Müller

Ludwig-Maximilians-Universität München

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Joel Tyndall

Research Interests

Explore related searches

Contact this professor

Articles (15)

Exploring Long Arm Amide-Linked Side Chains in the Design of Antifungal Azole Inhibitors of Sterol 14α-Demethylase (CYP51)

Covalent Isothiocyanate Inhibitors of Macrophage Migration Inhibitory Factor as Potential Colorectal Cancer Treatments

Development of Putative Bivalent Dicovalent Ligands for the Adenosine A1 Receptor

The Molecular Basis of the Intrinsic and Acquired Resistance to Azole Antifungals in Aspergillus fumigatus

Synthesis and antifungal evaluation of novel triazole derivatives bearing a pyrazole-methoxyl moiety

Synthesis and Characterization of a Cannabinoid Type 2 Receptor Photoactivated Prodrug

Characterisation of <i>Candida parapsilosis</i> CYP51 as a Drug Target Using <i>Saccharomyces cerevisiae</i> as Host

Synthesis and Biological Evaluation of Aurachin D Analogues as Inhibitors of Mycobacterium tuberculosis Cytochrome bd Oxidase

S-217622, a 3CL Protease Inhibitor and Clinical Candidate for SARS-CoV-2

Structure-activity relationships of N-terminal variants of peptidomimetic tissue transglutaminase inhibitors

Improving Antibacterial Activity of a HtrA Protease Inhibitor JO146 against Helicobacter pylori: A Novel Approach Using Microfluidics-Engineered PLGA Nanoparticles

Design, synthesis and biological evaluation of P2-modified proline analogues targeting the HtrA serine protease in Chlamydia

Covalent cannabinoid receptor ligands – structural insight and selectivity challenges

Structural Insights into the Azole Resistance of the <i>Candida albicans</i> Darlington Strain Using <i>Saccharomyces cerevisiae</i> Lanosterol 14α-Demethylase as a Surrogate

Self-immolative Linkers in Prodrugs and Antibody Drug Conjugates in Cancer Treatment

Collaborators (11)

Wilhelmina Huston

Michelle Glass

Natasha Grimsey

Malcolm Rutledge

Andrea J. Vernall

Claire Simons

Matthew Phillips

Brian Monk

Sigurd Wilbanks

Arlene McDowell

Christoph Müller

Make your next move.